Search

Your search keyword '"Ueno, Kentaro"' showing total 39 results
Start Over Author "Ueno, Kentaro" Search Limiters Full Text
39 results on '"Ueno, Kentaro"'

3. Combination of transbronchoscopic oxygen insufflation and a digital chest drainage system in endobronchial occlusion: a hybrid technique for localization of fistula in intractable pneumothorax

Author

Ueno, Shunsuke, Nakai, Toshiyuki, Mizumori, Yasuyuki, Ishiyama, Fukumichi, Ueno, Kentaro, Kouno, Manami, Oshima, Yuri, Nishimura, Misako, Miyamoto, Atsushi, Matsumoto, Yoshiya, Sawa, Kenji, Sato, Kanako, Yamada, Kazuhiro, Watanabe, Tetsuya, Asai, Kazuhisa, Otani, Kenichiro, and Kawaguchi, Tomoya

Published
2024
Full Text
View/download PDF

4. Safety assessment of robotic gastrectomy and analysis of surgical learning process: a multicenter cohort study

Author

Shimoike, Norihiro, Nishigori, Tatsuto, Yamashita, Yoshito, Kondo, Masato, Manaka, Dai, Kadokawa, Yoshio, Itami, Atsushi, Kanaya, Seiichiro, Hosogi, Hisahiro, Satoh, Seiji, Hata, Hiroaki, Kan, Takatsugu, Kawada, Hironori, Yamamoto, Michihiro, Tanaka, Eiji, Tsunoda, Shigeru, Hisamori, Shigeo, Hida, Koya, Ueno, Kentaro, Tanaka, Shiro, and Obama, Kazutaka

Published
2022
Full Text
View/download PDF

5. Multicomponent Intervention for Overactive Bladder in Women

Author

Funada, Satoshi, primary, Luo, Yan, additional, Uozumi, Ryuji, additional, Watanabe, Norio, additional, Goto, Takayuki, additional, Negoro, Hiromitsu, additional, Ueno, Kentaro, additional, Ichioka, Kentaro, additional, Segawa, Takehiko, additional, Akechi, Tatsuo, additional, Ogawa, Osamu, additional, Akamatsu, Shusuke, additional, Kobayashi, Takashi, additional, and Furukawa, Toshi A., additional

Published
2024
Full Text
View/download PDF

9. Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer: a retrospective study

Author

Yamaguchi, Ayane, Honda, Maya, Ishiguro, Hiroshi, Kataoka, Masako, Kataoka, Tatsuki R., Shimizu, Hanako, Torii, Masae, Mori, Yukiko, Kawaguchi-Sakita, Nobuko, Ueno, Kentaro, Kawashima, Masahiro, Takada, Masahiro, Suzuki, Eiji, Nakamoto, Yuji, Kawaguchi, Kosuke, and Toi, Masakazu

Published
2021
Full Text
View/download PDF

11. Use of the index of pulmonary vascular disease for predicting long-term outcome of pulmonary arterial hypertension associated with congenital heart disease

Author

Chida-Nagai, Ayako, primary, Masaki, Naoki, additional, Maeda, Kay, additional, Sasaki, Konosuke, additional, Sato, Hiroki, additional, Muneuchi, Jun, additional, Ochiai, Yoshie, additional, Murayama, Hiroomi, additional, Tahara, Masahiro, additional, Shiono, Atsuko, additional, Shinozuka, Atsushi, additional, Kono, Fumihiko, additional, Machida, Daisuke, additional, Toyooka, Shinichi, additional, Sugimoto, Seiichiro, additional, Nakamura, Kazufumi, additional, Akagi, Satoshi, additional, Kondo, Maiko, additional, Kasahara, Shingo, additional, Kotani, Yasuhiro, additional, Koizumi, Junichi, additional, Oda, Katsuhiko, additional, Harada, Masako, additional, Nakajima, Daisuke, additional, Murata, Akira, additional, Nagata, Hazumu, additional, Yatsunami, Koichi, additional, Kobayashi, Tomio, additional, Matsunaga, Yoshikiyo, additional, Inoue, Takahiro, additional, Yamagishi, Hiroyuki, additional, Nakagawa, Naomi, additional, Ohtani, Katsuki, additional, Yamamoto, Masaki, additional, Ito, Yushi, additional, Hokosaki, Tatsunori, additional, Kuwahara, Yuta, additional, Masutani, Satoshi, additional, Nomura, Koji, additional, Wada, Tsutomu, additional, Sawada, Hirofumi, additional, Abiko, Masayuki, additional, Takahashi, Tatsunori, additional, Ishikawa, Yuichi, additional, Okada, Seigo, additional, Naitoh, Atsushi, additional, Toda, Takako, additional, Ando, Tatsuya, additional, Masuzawa, Akihiro, additional, Hoshino, Shinsuke, additional, Kawada, Masaaki, additional, Nomura, Yuichi, additional, Ueno, Kentaro, additional, Ohashi, Naoki, additional, Tachibana, Tsuyoshi, additional, Cao, Yuchen, additional, Ueda, Hideaki, additional, Yanagi, Sadamitsu, additional, Koide, Masaaki, additional, Mitsushita, Norie, additional, Higashi, Kouji, additional, Minosaki, Yoshihiro, additional, Hayashi, Tomohiro, additional, Okamoto, Takashi, additional, Kuraishi, Kenji, additional, Ehara, Eiji, additional, Ishida, Hidekazu, additional, Horigome, Hitoshi, additional, Murakami, Takashi, additional, Takei, Kohta, additional, Ishii, Taku, additional, Harada, Gen, additional, Hirata, Yasutaka, additional, Maeda, Jun, additional, Tatebe, Shunsuke, additional, Ota, Chiharu, additional, Hayabuchi, Yasunobu, additional, Sakazaki, Hisanori, additional, Sasaki, Takashi, additional, Hirono, Keiichi, additional, Suzuki, Sayo, additional, Yasuda, Masahiro, additional, Takeda, Atsuhito, additional, Sawai, Madoka, additional, Miyaji, Kagami, additional, Kitagawa, Atsushi, additional, Nakai, Yosuke, additional, Kakimoto, Nobuyuki, additional, Agematsu, Kouta, additional, Manabe, Atsushi, additional, and Saiki, Yoshikatsu, additional

Published
2023
Full Text
View/download PDF

13. Successful coil embolization for pediatric internal mammary artery aneurysm after the Fontan procedure: A case report and literature review

Author

Takahashi, Yoshihiro, Ueno, Kentaro, Shiokawa, Naohiro, Nakae, Koji, Kawamura, Junpei, Morita, Yasuko, Hazeki, Daisuke, and Okamoto, Yasuhiro

Subjects
Case Report, Cardiology and Cardiovascular Medicine
Abstract

We herein describe the first pediatric case of an internal mammary artery (IMA) aneurysm caused by a median sternotomy. He was a 2-year-old with tricuspid atresia who underwent an extracardiac conduit Fontan procedure. On the 36th postoperative day, an asymptomatic left IMA aneurysm was detected via contrast computed tomography, which was successfully treated with coil embolization. The patient had no underlying disease such as vasculitis, connective tissue disease, or other hereditary diseases, and there were no episodes of infection or hypertension before or after the onset of the IMA aneurysm. Because the left IMA ran medially to the periphery and was in a vulnerable position during median sternotomy, we considered the IMA aneurysm was caused by the median sternotomy. We pediatric cardiologists should be aware that IMA aneurysms can occur in pediatric cardiac surgery, and we should be proactive in performing postoperative imaging studies in cases where the preoperative internal thoracic artery runs medially toward the periphery. LEARNING OBJECTIVE: Internal mammary artery (IMA) aneurysm is a rare vascular disease, especially in children. One-third of adult IMA aneurysms have been reported to be caused by sternotomy, but not in children. We report the first pediatric case of an IMA aneurysm caused by sternotomy. We should recognize that there is a potential risk of IMA aneurysms in pediatric cardiac surgery as well.

Published
2022

14. Dexmedetomidine versus haloperidol for sedation of non-intubated patients with hyperactive delirium during the night in a high dependency unit: study protocol for an open-label, parallel-group, randomized controlled trial (DEX-HD trial).

Author

Minami, Takuma, Watanabe, Hirotoshi, Kato, Takao, Ikeda, Kaori, Ueno, Kentaro, Matsuyama, Ai, Maeda, Junya, Sakai, Yoji, Harada, Hisako, Kuriyama, Akira, Yamaji, Kyohei, Kitajima, Naoki, Kamei, Jun, Takatani, Yudai, Sato, Yuki, Yamashita, Yugo, Mizota, Toshiyuki, and Ohtsuru, Shigeru

Subjects
INTENSIVE care units, DRUG efficacy, EXPERIMENTAL design, ANESTHESIA, TIME, TERTIARY care, PATIENTS, INVESTIGATIONAL drugs, IMIDAZOLES, HALOPERIDOL, RANDOMIZED controlled trials, TREATMENT effectiveness, DELIRIUM, EMERGENCY medical services, RESEARCH funding, PATIENT safety, EVALUATION
Abstract

Background: Delirium is common in critically ill patients. Haloperidol has long been used for the treatment of delirium. Dexmedetomidine has recently been used to treat delirium among intubated critically ill patients. However, the efficacy of dexmedetomidine for delirium in non-intubated critically ill patients remains unknown. We hypothesize that dexmedetomidine is superior to haloperidol for sedation of patients with hyperactive delirium, and would reduce the prevalence of delirium among non-intubated patients after administration. We will conduct a randomized controlled trial to compare dexmedetomidine and haloperidol for the treatment of nocturnal hyperactive delirium in non-intubated patients in high dependency units (HDUs). Methods: This is an open-label, parallel-group, randomized controlled trial to compare the efficacy and safety of dexmedetomidine and haloperidol for nocturnal hyperactive delirium in non-intubated patients at two HDUs of a tertiary hospital. We will recruit consecutive non-intubated patients who are admitted to the HDU from the emergency room, and allocate them in a 1:1 ratio to the dexmedetomidine or haloperidol group in advance. The allocated investigational drug will be administered only when participants develop hyperactive delirium (Richmond Agitation-Sedation Scale [RASS] score ≥1 and a positive score on the Confusion Assessment Method for the ICU between 19:00 and 6:00 the next day) during the night at an HDU. Dexmedetomidine is administered continuously, while haloperidol is administered intermittently. The primary outcome is the proportion of participants who achieve the targeted sedation level (RASS score of between -3 and 0) 2h after the administration of the investigational drug. Secondary outcomes include the sedation level and prevalence of delirium on the day following the administration of the investigational drugs, and safety. We plan to enroll 100 participants who develop nocturnal hyperactive delirium and receive one of the two investigational drugs. Discussion: This is the first randomized controlled trial to compare the efficacy and safety of dexmedetomidine and haloperidol for sedation of non-intubated critically ill patients with hyperactive delirium in HDUs. The results of this study may confirm whether dexmedetomidine could be another option to sedate patients with hyperactive delirium. Trial registration: Japan Registry of Clinical Trials, jRCT1051220015, registered on 21 April 2022. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

16. Electrocardiographic Diagnosis of Hypertrophic Cardiomyopathy in the Pre- and Post-Diagnostic Phases in Children and Adolescents

Author

Yoshinaga, Masao, primary, Horigome, Hitoshi, additional, Ayusawa, Mamoru, additional, Yasuda, Kazushi, additional, Kogaki, Shigetoyo, additional, Doi, Shozaburo, additional, Tateno, Sigeru, additional, Ohta, Kunio, additional, Hokosaki, Tatsunori, additional, Nishihara, Eiki, additional, Iwamoto, Mari, additional, Sumitomo, Naokata, additional, Ushinohama, Hiroya, additional, Izumida, Naomi, additional, Tauchi, Nobuo, additional, Kato, Yoshiaki, additional, Kato, Taichi, additional, Chisaka, Toshiyuki, additional, Higaki, Takashi, additional, Yoneyama, Tatsuya, additional, Abe, Katsumi, additional, Nozaki, Yoshihiro, additional, Komori, Akiko, additional, Kawai, Satoru, additional, Ninomiya, Yumiko, additional, Tanaka, Yuji, additional, Nuruki, Norihito, additional, Sonoda, Masahiro, additional, Ueno, Kentaro, additional, Hazeki, Daisuke, additional, Nomura, Yuichi, additional, Sato, Seiichi, additional, Hirono, Keiichi, additional, Hosokawa, Susumu, additional, Takechi, Fumie, additional, Ishikawa, Yuichi, additional, Hata, Tadayoshi, additional, Ichida, Fukiko, additional, Ohno, Seiko, additional, Makita, Naomasa, additional, Horie, Minoru, additional, Matsushima, Shouji, additional, Tsutsui, Hiroyuki, additional, Ogata, Hiromitsu, additional, Takahashi, Hideto, additional, and Nagashima, Masami, additional

Published
2021
Full Text
View/download PDF

25. Increased Burden of Ion Channel Gene Variants Is Related to Distinct Phenotypes in Pediatric Patients With Left Ventricular Noncompaction

Author

Hirono, Keiichi, primary, Hata, Yukiko, additional, Miyao, Nariaki, additional, Okabe, Mako, additional, Takarada, Shinya, additional, Nakaoka, Hideyuki, additional, Ibuki, Keijiro, additional, Ozawa, Sayaka, additional, Origasa, Hideki, additional, Nishida, Naoki, additional, Ichida, Fukiko, additional, Takeda, Atsuhito, additional, Shimabukuro, Atsuya, additional, Akita, Chisato, additional, Fukumi, Daichi, additional, Nishihara, Eiki, additional, Tsuda, Etsuko, additional, Sakaguchi, Heima, additional, Ishida, Hidekazu, additional, Tomita, Hideshi, additional, Kise, Hiroaki, additional, Nagamine, Hiroki, additional, Uchiyama, Hiroki, additional, Katayama, Hiromi, additional, Ooki, Hiroo, additional, Nishikawa, Hiroshi, additional, Ono, Hiroshi, additional, Horigome, Hisanori Sakazaki, Hitoshi, additional, Muneuchi, Jun, additional, Yoshimoto, Jun, additional, Soumura, Junpei, additional, Kamada, Masahiro, additional, Yasuda, Kazushi, additional, Ikeda, Kazuyuki, additional, Yasuda, Keiji, additional, Kurosaki, Kenichi, additional, Mine, Kenji, additional, Ueno, Kentaro, additional, Takigiku, Kiyohiro, additional, Ogawa, Kiyoshi, additional, Inaguma, Kotaro, additional, Oyama, Kotaro, additional, Urayama, Kotaro, additional, Takahashi, Kunihiko, additional, Ohta, Kunio, additional, Nakazawa, Makoto, additional, Nakayashiro, Mami, additional, Ayusawa, Mamoro, additional, Toyono, Manatomo, additional, Nii, Masaki, additional, Miura, Masaru, additional, Fujino, Mitsuhiro, additional, Kuwabara, Naoshi, additional, Momoi, Nobuo, additional, Tsujii, Nobuyuki, additional, Motoki, Noriko, additional, Matsuo, Osamu, additional, Baba, Reizo, additional, Inuzuka, Ryo, additional, Kido, Sachiko, additional, Iwashima, Satoru, additional, Yasukochi, Satoshi, additional, Okada, Seigo, additional, Sato, Seiichi, additional, Mitsuru, Seki, additional, Kogaki, Shigetoyo, additional, Hoshino, Shinsuke, additional, Tsukano, Shinya, additional, Fujita, Shuhei, additional, Kimura, Sumito, additional, Urata, Susumu, additional, Kato, Taichi, additional, Toda, Takako, additional, Uchiyama, Takamichi, additional, Shindo, Takahiro, additional, Higaki, Takashi, additional, Kobayashi, Tomio, additional, Ozaki, Tomoyasu, additional, Tanaka, Yasuhiko, additional, Katsube, Yasuhiro, additional, Hamabuchi, Yasunobu, additional, Kajiyama, Yo, additional, Yoshida, Yoko, additional, Murakami, Yosuke, additional, Abe, Yuriko, additional, Hiraumi, Yoshimi, additional, Fukuda, Yutaka, additional, and Odanaka, Yutaka, additional

Published
2020
Full Text
View/download PDF

27. シクロフォスファミドに伴う重症心筋障害を合併した患者に対する補助循環装置の有用性について

Author

NAKAE Koji, UENO Kentaro, KAWAMURA Junpei, YANAGIMOTO Kosuke, EGUCHI Taisuke, NOMURA Yuichi, KAKIHANA Yasuyuki, and KAWANO Yoshifumi

Subjects
intra-aortic balloon pump (IABP), cardiotoxicity, percutaneous cardiopulmonary support (PCPS), cyclophosphamide, bone marrow transplantation (BMT)
Abstract

Cyclophosphamide is one of the most widely used antineoplastic drugs. It is also a potent immunosuppressive agent administered to patients undergoing bone marrow transplantation (BMT). Here we report two cases of aplastic anemia in which severe cardiac dysfunction followed the serial administration of cyclophosphamide (50 mg/m² for 4 days). Both patients gradually developed dyspnea and showed oliguria 3–4 days after BMT. Cardiomegaly was seen on chest X-ray. Echocardiography showed reduced left ventricular contraction, pericardial effusion, and myocardial thickening. Cyclophosphamide-induced cardiotoxicity was suspected and the patients were treated accordingly but were refractory to pharmacotherapy. They were transferred to the intensive care unit where they received mechanical cardiopulmonary support, which improved left ventricular cardiac performance and led to a regression of myocardial thickening. Although both patients died because of severe pulmonary and renal complications, the rapid initiation of mechanical cardiopulmonary support may be a useful strategy in patients with a deteriorating condition, by allowing cardiac recuperation and therefore gaining time for further, potentially life-saving treatment., シクロフォスファミドは抗腫瘍薬として、また骨髄移植の前処置時に免疫抑制薬としても広く使用されている。われわれは、シクロフォスファミド投与後（50mg/m2 4 日間）に重症心筋障害をきたした再生不良性貧血の2 症例を経験した。両患者ともに移植後3-4 日で呼吸困難、乏尿がみられ、胸部エックス線で心拡大、心エコー検査で左室収縮能の低下、心嚢液貯留および心筋肥厚所見を認めた。シクロフォスファミドによる重症心筋障害から循環不全をきたしたと考え、循環作動薬で加療したが改善せず、集中治療室で経皮的心肺補助装置、大動脈内バルーンパンピングを用いた補助循環装置を導入した。補助循環装置での治療開始後、心収縮力は改善し、心筋肥厚も軽快した。両患者ともに補助循環装置から離脱することができたが、重篤な移植後合併症で死亡した。シクロフォスファミドによる重症心筋障害はまれに発生するが、早期の診断ならびに補助循環装置を用いた集中治療管理を行うことで心筋の回復が得られ、予後の改善に繋がる可能性がある。

Published
2015

34. Characteristics of Patients with Kawasaki Disease Who Showed Non-Responsiveness to Initial Intravenous Immunoglobulin Treatment Who Were Predicted as Being at Low Risk of Being a Non-Responder

Author

Kawamura, Junpei, primary, Nomura, Yuichi, additional, Masuda, Kiminori, additional, Morita, Yasuko, additional, Yoshishige, Michiko, additional, Yanagimoto, Kosuke, additional, Ueno, Kentaro, additional, Eguchi, Taisuke, additional, and Kawano, Yoshifumi, additional

Published
2014
Full Text
View/download PDF

37. Successful Treatment of Congenital Chylothorax by Early Use of Prednisolone: A Case Report.

Author

Hirano K, Nakae K, Matsunaga M, Ueno K, and Okamoto Y

Abstract

Congenital chylothorax is the most common form of pleural effusion during the neonatal period; however, no treatment strategy exists. The pathogenesis and etiology of this disease are not fully understood; hence, several cases are difficult to treat. Some patients with chylothorax may not survive due to severe respiratory distress. Prednisolone (PSL) is sometimes used to treat congenital chylothorax but is rarely used in the early postnatal period. In this report, we describe a neonate with prenatal pleural effusion who was successfully treated with PSL from day one after requiring endotracheal intubation and ventilator management due to a postnatal diagnosis of chylothorax. The patient was extubated at four days of age, weaned from the ventilator at 10 days of age, and discharged home at 40 days of age after a total of 10 days of administration. Although the mechanism of action of PSL in chylothorax is unknown, and because it is a steroid, side effects such as gastrointestinal perforation and susceptibility to infection should be noted. The present case suggests the utility of early PSL administration for the treatment strategy of congenital chylothorax., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2024, Hirano et al.)

Published
2024
Full Text
View/download PDF

38. Corrigendum: Use of the index of pulmonary vascular disease for predicting longterm outcome of pulmonary arterial hypertension associated with congenital heart disease.

Author

Chida-Nagai A, Masaki N, Maeda K, Sasaki K, Sato H, Muneuchi J, Ochiai Y, Murayama H, Tahara M, Shiono A, Shinozuka A, Kono F, Machida D, Toyooka S, Sugimoto S, Nakamura K, Akagi S, Kondo M, Kasahara S, Kotani Y, Koizumi J, Oda K, Harada M, Nakajima D, Murata A, Nagata H, Yatsunami K, Kobayashi T, Matsunaga Y, Inoue T, Yamagishi H, Nakagawa N, Ohtani K, Yamamoto M, Ito Y, Hokosaki T, Kuwahara Y, Masutani S, Nomura K, Wada T, Sawada H, Abiko M, Takahashi T, Ishikawa Y, Okada S, Naitoh A, Toda T, Ando T, Masuzawa A, Hoshino S, Kawada M, Nomura Y, Ueno K, Ohashi N, Tachibana T, Cao Y, Ueda H, Yanagi S, Koide M, Mitsushita N, Higashi K, Minosaki Y, Hayashi T, Okamoto T, Kuraishi K, Ehara E, Ishida H, Horigome H, Murakami T, Takei K, Ishii T, Harada G, Hirata Y, Maeda J, Tatebe S, Ota C, Hayabuchi Y, Sakazaki H, Sasaki T, Hirono K, Suzuki S, Yasuda M, Takeda A, Sawada M, Miyaji K, Kitagawa A, Nakai Y, Kakimoto N, Agematsu K, Manabe A, and Saiki Y

Abstract

[This corrects the article DOI: 10.3389/fcvm.2023.1212882.]., (© 2024 Chida-Nagai, Masaki, Maeda, Sasaki, Sato, Muneuchi, Ochiai, Murayama, Tahara, Shiono, Shinozuka, Kono, Machida, Toyooka, Sugimoto, Nakamura, Akagi, Kondo, Kasahara, Kotani, Koizumi, Oda, Harada, Nakajima, Murata, Nagata, Yatsunami, Kobayashi, Matsunaga, Inoue, Yamagishi, Nakagawa, Ohtani, Yamamoto, Ito, Hokosaki, Kuwahara, Masutani, Nomura, Wada, Sawada, Abiko, Takahashi, Ishikawa, Okada, Naitoh, Toda, Ando, Masuzawa, Hoshino, Kawada, Nomura, Ueno, Ohashi, Tachibana, Cao, Ueda, Yanagi, Koide, Mitsushita, Higashi, Minosaki, Hayashi, Okamoto, Kuraishi, Ehara, Ishida, Horigome, Murakami, Takei, Ishii, Harada, Hirata, Maeda, Tatebe, Ota, Hayabuchi, Sakazaki, Sasaki, Hirono, Suzuki, Yasuda, Takeda, Sawada, Miyaji, Kitagawa, Nakai, Kakimoto, Agematsu, Manabe and Saiki.)

Published
2024
Full Text
View/download PDF

39. Case Report: 18 F-FDG PET-CT for Diagnosing Prosthetic Device-Related Infection in an Infant With CHD.

Author

Kawamura J, Ueno K, Taimura E, Matsuba T, Imoto Y, Jinguji M, and Kawano Y

Abstract

Patients who have undergone cardiac surgery using prosthetic devices have an increased risk of developing prosthetic device-related infection and mediastinitis. However, accurate diagnosis of prosthetic device-related infection can be difficult to evaluate and treat with antibiotic therapy alone. In recent years, 18 F-fluorodeoxyglucose positron emission tomography-computed tomography ( 18 F-FDG PET-CT) has made promising contributions to detect infective endocarditis, pacemaker infections, or other inflammations. Nevertheless, 18 F-FDG PET-CT for congenital heart disease (CHD) with device infection has been sparsely reported. We present an infantile girl diagnosed with pulmonary atresia with a ventricular septal defect who underwent replacement of the right ventricle-to-pulmonary artery (RV-PA) conduit for improvement cyanosis. She developed high fever and was diagnosed with mediastinitis and bacteremia by Pseudomonas aeruginosa (P. aeruginosa) on postoperative day 4. Mediastinal drainage and 6 weeks of antibiotic therapy improved her condition, but bacteremia flared up on postoperative day 56. Despite a long course of antibiotic therapy, she had two more recurrences of bacteremia with the detection of P. aeruginosa . Echocardiography and chest contrast CT showed no evidence of vegetation and mediastinitis. On postoperative day 115, 18 F-FDG PET-CT revealed an accumulation on the RV-PA conduit (SUV max 3.4). Finally, she developed an infectious ventricular pseudo-aneurysm on postoperative day 129 and underwent aneurysm removal and RV-PA conduit replacement on postoperative day 136. Our case showed the importance of 18 F-FDG PET-CT for diagnosing specific localization of prosthetic device-related infection which is hard to detect using other imaging techniques. It can be a useful diagnostic tool for infantile patients with CHD with cardiac prosthetic devices and improve subsequent clinical treatments., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Kawamura, Ueno, Taimura, Matsuba, Imoto, Jinguji and Kawano.)

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results